Home » Clinical Trials » Search Clinical Trials Therapeutic Areas: Gastroenterology | Pediatrics/Neonatology | Genetic Disease | Neurology
Fabry Disease Clinical Trials
A listing of Fabry Disease medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.
Filter by:
Phase:
All
N/A
0
1
1/2
2
2/3
3
4
Gender:
Both
Male
Female
Age:
Location:
All
US: Alabama
US: Alaska
US: Arizona
US: Arkansas
US: California
US: Colorado
US: Connecticut
US: Delaware
US: District of Columbia
US: Florida
US: Georgia
US: Hawaii
US: Idaho
US: Illinois
US: Indiana
US: Iowa
US: Kansas
US: Kentucky
US: Louisiana
US: Maine
US: Maryland
US: Massachusetts
US: Michigan
US: Minnesota
US: Mississippi
US: Missouri
US: Montana
US: Nebraska
US: Nevada
US: New Hampshire
US: New Jersey
US: New Mexico
US: New York
US: North Carolina
US: North Dakota
US: Ohio
US: Oklahoma
US: Oregon
US: Pennsylvania
US: Rhode Island
US: South Carolina
US: South Dakota
US: Tennessee
US: Texas
US: Utah
US: Vermont
US: Virgin Islands
US: Virginia
US: Washington
US: West Virginia
US: Wisconsin
US: Wyoming
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, The Democratic Republic of the
Cook Islands
Costa Rica
Côte D'ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island And Mcdonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle Of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, The Former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts And Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and The Grenadines
Samoa
San Marino
Sao Tome And Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard And Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad And Tobago
Tunisia
Turkey
Turkmenistan
Turks And Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis And Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
First 1 2 Last
California
Cedars-Sinai Medical Center
A clinical trial seeking patients for a research study for the treatment of Fabry Disease
GSK Investigational Site
Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease
Georgia
Department of Human Genetics, Emory University School of Medicine
Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease
Atlanta Georgia Updated
Patients are needed to participate in a clinical research study of Iohexol to evaluate Fabry Disease
GSK Investigational Site
Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease
Kansas
University of Kansas Medical Center
Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease
Maryland
Johns Hopkins University School of Medicine
Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease
Massachusetts
GSK Investigational Site
Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease
Minnesota
University of Minnesota, Fariview
Patients are needed to participate in a clinical research study of Gabapentin and placebo to evaluate Fabry Disease or Neuropathic Pain
New York
GSK Investigational Site
Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease
North Carolina
Duke University Medical Center
Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease
Ohio
Eye and Ear Institute
A clinical trial seeking patients for a research study for the treatment of Fabry Disease
Pennsylvania
GSK Investigational Site
Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease
Texas
GSK Investigational Site
Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease
Research Baylor Institute of Metabolic Disease
Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease
Virginia
O & O Alpan LLC
Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease
Fairfax Virginia Updated
Patients are needed to participate in a clinical research study of Iohexol to evaluate Fabry Disease
GSK Investigational Site
Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease
Washington
GSK Investigational Site
Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease
Argentina
GSK Investigational Site
Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease
Australia
GSK Investigational Site
Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease
GSK Investigational Site
A clinical research study of migalastat HCl for the treatment of Fabry Disease
GSK Investigational Site
Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease
Royal Melbourne Hospital
Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease
Austria
Universitätsklinikum für Neurologie
A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident
Belgium
Liège Updated
Patients are needed to participate in a clinical research study of Iohexol to evaluate Fabry Disease
Brazil
GSK Investigational Site
Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease
Canada
GSK Investigational Site
Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease
Croatia
Department of Neurology, University Hospital Sestre Milosrdnice
A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident
France
GSK Investigational Site
Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease
Hopital Neurologique de Lyon, Service d'urgences Neurovasculaires
A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident
Georgia
Department of Neurology, S. Khechinashvili University clinic of Tbilisi state medical university
A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident
Germany
Department of Neurology, Klinikum Hohe Warte
A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident
Charite Campus Benjamin Franklin, Dept. of Neurology
A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident
Department of Neurology, Allgemeines Krankenhaus Celle
A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident
Department of Neurology, Klinikum Chemnitz gGmbH
A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident
Department of Neurology, Universitaetsklinikum Carl Gustav Carus
A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident
View More »
Heinrich-Heine-University Duesseldorf, Dept. of Neurology
A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident
University of Giessen-Marburg Dept. of Neurology
A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident
Department of Neurology, Universitaetsklinikum Hamburg-Eppendorf
A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident
Department of Neurology, Universitaetsklinikum Jena
A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident
Department of Neurology, Universitaetsklinikum Leipzig
A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident
University of Mainz
A clinical study for patients with Fabry Disease
Dept. of Neurology, Ökumenisches Hainich Klinikum gGmbH
A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident
Ludwig-Maximilians-University of Munich, Klinikum München-Großhadern, Dept. of Neurology
A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident
Department of Neurology, University Tuebingen
A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident
University of Ulm, Department of Neurology
A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident
First 1 2 Last
